ABSTRACT Background: The suggestion that body mass index (BMI) cutoffs to define obesity should differ in persons of Polynesian descent compared with Europeans is based principally on the observation that persons of Polynesian descent have a relatively higher proportion of lean body mass for a given BMI. Objectives: The objectives were to determine whether the relation between BMI, waist circumference, and metabolic comorbidity differs in the 2 major ethnic groups in New Zealand and to ascertain whether ethnicity-specific BMI and waist circumference cutoffs for obesity are justified for Māori (indigenous New Zealanders). Design: Subjects included a convenience sample of 1539 men and women aged 17-82 y (47% Māori, 53% white) with measures of BMI, waist circumference, blood pressure, fasting insulin, glucose, and lipids. The sensitivity and specificity of BMI (in kg/m 2 ; 30 and 32), waist circumference (80 and 88 cm in women, 94 and 102 cm in men), and waist-to-height ratio (WHtR; 0.6) in relation to insulin sensitivity, insulin resistance, and the metabolic syndrome were determined. Receiver operating characteristic curves and areas under the curve (AUCs) were also calculated. Results: No ethnic or sex differences between AUCs were observed for BMI, waist circumference, or WHtR, which showed that these anthropometric measures perform similarly in Māori and European men and women and correctly discriminate between those with and without insulin resistance or the metabolic syndrome 79-87% of the time. Any increase in specificity from a higher BMI cutoff of 32 in Māori was offset by appreciable reductions in sensitivity. Conclusion: These findings argue against having different BMI or waist circumference cutoffs for people of Polynesian descent. Am J Clin Nutr 2010;92:390-7.
INTRODUCTION
Body mass index (BMI) is the most widely used indicator of body fatness and has application to both public health and clinical practice. In the context of national and international health care, BMI cutoffs are applied to population data to compare rates of overweight and obesity nationally and internationally, develop policy, plan prevention programs, and assess the benefit of interventions. In the clinical context, BMI measurement is used to identify individuals at risk of comorbidities, in conjunction with other clinical variables, to determine treatment regimes and sometimes to monitor the effects of treatment.
The relation between BMI and percentage body fat is influenced by age, sex, and ethnicity (1) (2) (3) . In some Asian populations, percentage body fat is higher for a given BMI than is the case for Europeans (4) (5) (6) . Conversely, some Māori and Polynesian groups have been reported to have a lesser degree of body fat than do Europeans of the same age and sex and with a similar BMI (5, (7) (8) (9) (10) (11) . These observations have led to the suggestion that BMI cutoffs used to define overweight and obesity should differ in Polynesian and Māori populations when compared with Europeans (5, 7, 8, 10, (12) (13) (14) . Accordingly, the most recent national nutrition survey in New Zealand used a BMI (in kg/m 2 ) cutoff of 32 to define obesity for Māori (indigenous New Zealanders) and Pacific Island adults and the conventional cutoff of 30 for Europeans (15) as have other research projects in the region (16) .
Whether BMI varies in relation to percentage body fat in different ethnic groups is immaterial if ethnic variation in the relation between BMI and comorbidities is not apparent. It is arguably more important that BMI thresholds be based on the risk of developing the comorbidities related to body fatness (the purpose for which they were initially used) rather than on variation in body composition (17, 18) . This may be particularly relevant for Māori and other Polynesian populations, among whom obesity and type 2 diabetes rates are exceptionally high (19, 20) .
Most of the studies to date that have compared body composition in relation to BMI in European and Polynesian populations have not included measures of comorbidities, nor have they all included a sufficient number of males and females with a wide age range to ensure that differences apply across the age spectrum (5, 7, 10, 12, 21) . The aim of our study was to determine whether different BMI or waist circumference cutoffs are warranted to define overweight and obesity in those of Māori descent relative to various measures of diabetes and cardiovascular risk.
SUBJECTS AND METHODS
A nonrepresentative convenience sample of all Māori and European adults aged 17 y who had taken part in various studies in our laboratory, and who had measurements of BMI, waist circumference, fasting lipids/glucose/insulin, and blood pressure, were included in the study (n = 1539). The reporting of data followed the STROBE guidelines for observational studies (www.strobe-statement.org). Data were derived from baseline measures of subjects who had participated in dietary interventions (19, (22) (23) (24) and from those who volunteered for risk factor screening in a diabetes prevalence survey (25) . Additional Māori participants were sought by using culturally appropriate techniques, including discussions with community leaders and snowballing techniques (L Brooking, unpublished data, 2004). Ethnicity was determined by self-identification with the use of the New Zealand census question according to standard protocol. However, in addition to self-identifying as Māori, Māori participants were required to be familiar with their whakapapa (genealogy) and to have knowledge of their iwi, hapu, and marae (tribal affiliations). A previous diagnosis of type 2 diabetes or other chronic disease (cancers and chronic ischemic heart disease) was the only additional exclusion criterion. All studies were approved by the Ethics Committee of the University of Otago (Dunedin, New Zealand) or the Lower South Regional Ethics Committee (Dunedin, New Zealand), and all participants gave informed consent to participate in the various research projects. The approvals included provision for analyses relating to nutrition issues and body weight, and all data were cleansed of personal identifiers before analysis.
Measurements
Duplicate measures of height (Harpenden stadiometer; Holtain Ltd, Crymych, United Kingdom), weight (electronic scales), and waist circumference (at the midpoint between the anterior superior iliac crest and the lowest rib) were obtained by trained researchers using standard techniques (26) . BMI was calculated as weight in kilograms divided by height in meters squared, and waist-to-height ratio (WHtR) was determined from waist circumference (cm) divided by height (cm). Blood pressure was recorded in duplicate after 5 min of rest by using random-zero sphygmomanometers. Fasting blood samples were obtained for measurement of glucose, insulin, lipids, and lipoproteins by using standard techniques (27) .
Definitions of cutoffs
The efficacy of several anthropometric indexes (BMI, waist circumference, and WHtR) to correctly classify adults according to the presence or absence of various risk factors for cardiovascular disease or diabetes was examined. High BMI was defined as 30 (28) and 32 (15) . Waist circumference action points of 80 and 88 cm in women and 94 and 102 cm in men (29, 30) were examined, and a high WHtR was defined as 0.6 (31). Adult Treatment Panel III criteria were used to define elevated values for triglycerides (1.69 mmol/L) and systolic blood pressure (130 mm Hg), low HDL cholesterol (1.04 mmol/L in men, 1.20 mmol/L in women), and the presence of the metabolic syndrome (having 3 of the following risk factors: elevated triglycerides, blood pressure, and waist circumference; low HDL cholesterol according to the values above; or a fasting glucose 100 mg/dL) (32) . Insulin sensitivity was estimated by using the McAuley index (33), calculated as Mffm/ I = exp[2.63-0.28ln(insulin) -0.31ln(triglycerides)]. Mffm/I is defined as glucose disposal adjusted for fat-free mass divided by average insulin during a glucose clamp, and the McAuley score is used to predict Mffm/I. A McAuley score 6.3 identifies a subject as having low insulin sensitivity (33) . Values for the homeostasis model assessment of insulin resistance (HOMA-IR) were calculated according to Matthews et al (34) . Insulin resistance was defined as having an HOMA-IR value 2.27, the upper quartile of the HOMA-IR distribution for 2198 control women drawn from the Women's Health Initiative observational study (35) .
Statistics
Data were analyzed by using STATA 161 (Stata Statistical Software, release 10.0; StataCorp, College Station, TX). Means (6SDs) or frequencies (percentages) are used to describe the characteristics of the Māori and European men and women in the sample. Sensitivity and specificity were estimated separately for Māori and Europeans. Receiver operating curve (ROC) analyses compared the equality of the ROC areas for 4 groups: Māori men and women and European men and women. A P value ,0.05 was taken as statistically significant.
RESULTS
Characteristics of the study population are shown in Table 1 . Māori women were significantly younger and shorter than their European counterparts, with higher BMIs. The Māori women were also more centrally distributed as indicated by higher waist circumference and WHtR values. Metabolic profiles also differed; HDL cholesterol was lower and LDL cholesterol higher in Māori women, but triglyceride concentrations were similar. Māori women had higher fasting insulin concentrations, which was reflected in lower HOMA scores, and lower systolic blood pressure values than European women. Some ethnic differences were also apparent in men. Māori men were of similar age to European men but were shorter and heavier with resultant higher BMI and waist values. Differences in metabolic indexes were observed for LDL cholesterol (higher in Māori men) and blood pressure (lower in Māori men) but not for any index of glucose metabolism. As shown in Table 2 , elevated BMI and waist circumferences were apparent in all ethnic/sex groups. Similarly, insulin resistance or reduced insulin sensitivity was present in 40% of all subjects, and almost one-third of participants met the criteria for presence of the metabolic syndrome. Some ethnic differences in prevalence were observed. More Māori participants of both sexes had elevated WHtR regardless of the criteria chosen, and there were significantly more obese Māori men (66.7%) than European men (32.5%, P , 0.05). However, the prevalence of insulin resistance, lowered insulin sensitivity, and the metabolic syndrome did not differ between Māori and European adults of either sex.
A BMI cutoff of 30 correctly identified 84% of Māori women and 88% of European women who were insulin resistant ( Table   3 ) but incorrectly labeled 40% (European) to 45% (Māori) of women as not being insulin resistant when in fact they were. Increasing the BMI cutoff to 32 improves the percentage of women correctly classified as not insulin resistant (specificity) but reduces the number of women who are correctly identified as insulin resistant. Raising the cutoff to 32 results in a small increase in the percentage of Māori women correctly classified overall from 68% to 72%, and a similar improvement is observed in European women. Comparable results are observed when BMI is used to discriminate between those women with and without reduced insulin sensitivity or the metabolic syndrome (Table 3) or with individual indexes of risk, including high blood pressure, reduced HDL-cholesterol concentrations, or elevated triglyceride concentrations (data not shown).
A waist circumference cutoff of 80 cm correctly identified nearly every woman with impaired insulin function or the metabolic syndrome. However, specificity was very poor (16-26%). Use of the higher waist circumference cutoff (88 cm) made appreciable improvements to specificity without major reductions in sensitivity. A WHtR cutoff of 0.6 performed very similarly as this higher action point for waist circumference (Table 3) . Interestingly, the use of high waist circumference in combination with an elevated BMI (any combination of the above cutoffs) does not improve the overall percentage of women correctly identified as being insulin resistant or as having the metabolic syndrome (correct classifications range from 71% to 73% in Māori and 74% to 76% in European women). A BMI cutoff of 30 also has high sensitivity in Māori men, correctly identifying 86-92% of those with cardiovascular risk factors ( Table 4) , but poor specificity (47-50%). As was seen in women, increasing the BMI cutoff to 32 improves the specificity, but lowers the sensitivity, and overall increases the percentage correctly classified by 7-10%. Specific BMI cutoffs performed quite differently in European men than in Māori men. In this group, a BMI of 30 had relatively poor sensitivity (56-63%) but high specificity (82-88%). However, similar numbers of European and Māori men were classified correctly overall by BMI.
Similar trends were observed for measures of central adiposity as were seen in women. The poor specificity of a waist circumference 94 cm as an indicator of cardiovascular risk would perhaps negate its use. In comparison, waist girths .102 cm or a WHtR 0.6 correctly discriminates between those with and without insulin resistance or the metabolic syndrome 73-80% of the time in both ethnic groups.
ROC curves show the ability of each anthropometric measure to correctly discriminate between those with and without a condition at all possible cutoffs of the screening measure. ROC curves are shown in Figure 1 , and the corresponding areas under the curve for BMI, waist circumference, and WHtR in relation to measures of insulin resistance and insulin sensitivity are shown in Table 5 . These clearly show that BMI performs similarly in each ethnic/sex group, correctly discriminating between those with and without appropriate insulin functioning 77-83% of the time. All 3 anthropometric techniques have similar discriminatory power as shown in Table 5 .
DISCUSSION
Our data clearly show that BMI and anthropometric measures of central adiposity perform similarly as indicators of cardiovascular risk in Māori and white adults. Commonly Table 5 .
recommended action points for BMI and waist circumference correctly discriminated between those with and without impaired insulin function or the metabolic syndrome approximately threefourths of the time. Little variation in predictive ability was observed according to sex or ethnicity.
The use of a BMI .32 to define obesity in Māori and Pacific Island adults arose as a result of studies that reported that Polynesian adults tend to be leaner for a given BMI than white adults (5, 7, 10, 12, 13 ). This conclusion is inappropriate for several reasons. First, few of these studies evaluated Māori and Pacific adults as separate groups. Several studies have now shown that percentage body fat measured by using dual-energy X-ray absorptiometry shows little or no difference (,2%) between Māori and white adults (12, 36, 37) . Such differences are unlikely to be clinically significant, particularly after accounting for measurement error (13) . Second, suggesting cutoffs for use in public health or clinical practice on the basis of BMI alone is inappropriate without evaluation of comorbidities. Advocating higher BMI cutoffs for Māori suggests that any associated health risks also do not become apparent until higher BMI values are observed. This is obviously not the case; Māori adults have an increased risk of the metabolic syndrome (20) and high blood pressure (38) and appear to be more susceptible to diabetes (25) , even for the same degree of adiposity (19) .
Whether specific measures of central fat distribution provide a more accurate indication of health risk than BMI remains a contentious issue (39) (40) (41) . WHtR has received considerable interest, given that it lends itself to the simple message of keeping your waist to less than half your height (31, 42, 43) . However, although a recent meta-analysis concluded that measures of central adiposity were the preferred indicators of hypertension, type 2 diabetes and dyslipidemia (44) , actual differences in their discriminatory power were very small and unlikely to be of clinical significance. In our analyses, waist circumference and WHtR had discriminatory power similar to BMI and did not vary according to sex and ethnicity. Each measure correctly discriminated between those with and without the condition 77-85% of the time. Although ethnic differences in discriminatory power have been reported (42), actual differences are very small and, we consider, insufficient to warrant the use of alternative cutoffs in different ethnic groups.
Our study has several strengths. It is reasonably large with a wide range of body size as evidenced by variation in BMI and waist values. We have also assessed the validity of various anthropometric indicators of health with a range of comorbidities. The particular strength of the present study is that it is the first to our knowledge to evaluate relations of BMI to comorbidities, information that is not reported in other studies which have sought to revise BMI cutoffs for overweight and obesity in Māori (5, 7, 10, 12) . However, a potentially important weakness of this and all other comparable studies is the fact that participants were volunteers. Our study included a relatively high proportion of overweight individuals because many were recruited for dietary interventions (24; registered at clinicaltrials.gov as NCT00128336), some specifically targeting weight management (19, 22, 23) . However, most of our Maori participants were obtained from a general community sample, albeit one with a high prevalence of diabetes and impaired glucose metabolism (25) . Overall, our study population had a higher proportion of overweight adults than is observed in the general New Zealand population, as might be expected in analyses using convenience samples. Furthermore, clear ethnic differences in the prevalence of comorbidities are apparent and well recognized (20, 25, 38) . These observations have the potential to lead to indeterminable sources of bias, but such an approach is inevitable in studies of this kind in which it is not feasible to study randomly selected individuals. It is possible that similar analyses undertaken in a representative sample would yield different estimates. Although our conclusions might have been strengthened by having a more direct measure of body fat, such as that obtained by using dual-energy X-ray absorptiometry, this would have been impractical given the nature and size of the study population.
The absence of ethnic and sex differences in the ROC curves for BMI and waist circumference as they relate to metabolic variables suggests that BMI and waist circumference perform similarly in each group. Although increasing BMI and waist circumference cutoffs for Māori is associated with a modest increase in specificity, doing so results in appreciable reductions in sensitivity. Thus, there would appear to be no justification for recommending higher cutoffs for Māori, because this approach would fail to identify many individuals who have risk factors for cardiovascular disease. A similar situation is likely to apply to other groups of Polynesian descent.
